Metraipolis › archive › dc_ca58685e4b45

A selective RPL15 PROTAC degrader enhances anti-PD-1 immunotherapy in a murine melanoma tumor model — Europe PMC PMID:41276688

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41276688
DOI
10.1038/s41388-[numero omesso]-4
License (as archived)
solo-consultazione
Archived
2026-11-08T08:10:25.238Z
SHA-256 of the archived text
1d411a029f994fccd84f3b25ef80acb68169df0d9aee97b360097cdbc99912ad
Stable URL of this page
https://metraipolis.com/documento/dc_ca58685e4b45

How to cite

A selective RPL15 PROTAC degrader enhances anti-PD-1 immunotherapy in a murine melanoma tumor model — Europe PMC PMID:41276688 — Europe PMC (en), https://europepmc.org/article/MED/41276688 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ca58685e4b45 (Metraipolis archive dc_ca58685e4b45, sha256 1d411a029f994fccd84f3b25ef80acb68169df0d9aee97b360097cdbc99912ad)
BibTeX
@misc{dcca58685e4b45,
  title = {A selective RPL15 PROTAC degrader enhances anti-PD-1 immunotherapy in a murine melanoma tumor model — Europe PMC PMID:41276688},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41276688},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ca58685e4b45; sha256 1d411a029f994fccd84f3b25ef80acb68169df0d9aee97b360097cdbc99912ad},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41276688. Agents can read the archived copy with the MCP tool read_document.